Vision SCS F2

Insider Reports History

Location
Luxemburg, Luxembourg
Signature
/s/ Alain Renard /s/ Christian Francois, for F2 Vision SCS
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vision SCS F2:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1,255,963 $15,649,299 $12.46 04 Aug 2022 Direct
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1,136,525 $14,161,102 $12.46 02 Aug 2022 By Globeways Holdings Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 622,175 $7,752,301 $12.46 02 Aug 2022 By F2-TPO Investments, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 537,392 $6,695,904 $12.46 02 Aug 2022 By F2 Bioscience I 2017 Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 325,333 $4,053,649 $12.46 02 Aug 2022 By F2 MG Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 214,798 $2,676,383 $12.46 02 Aug 2022 By F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 207,803 $2,589,225 $12.46 02 Aug 2022 By Morana Jovan-Embiricos
Cullinan Oncology, Inc. 10%+ Owner Common Stock 104,762 $1,305,335 $12.46 02 Aug 2022 By F2 GC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 71,599 $892,124 $12.46 02 Aug 2022 By F2 Bio TD, LLC

Insider Reports Filed by Vision SCS F2

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Oncology, Inc. 02 Aug 2022 3 -$711,676 4 10%+ Owner 04 Aug 2022, 21:01
CGEM Cullinan Oncology, Inc. 12 May 2022 4 -$4,045,791 4 10%+ Owner 16 May 2022, 20:54
CGEM Cullinan Oncology, Inc. 11 Jan 2022 1 $0 4 10%+ Owner 13 Jan 2022, 16:22